JOINT FILING AGREEMENT
EXHIBIT 99.1
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the common stock, $0.001 par value, of Synageva BioPharma Corp. is being filed with the Securities and Exchange Commission on behalf of each of them.
January 9, 2013
XXXXX BROS. ADVISORS, LLC | |||
By: | /s/ Xxxxx X. Xxxxxxx | ||
Name: Xxxxx X. Xxxxxxx | |||
Title: President | |||
By: | /s/ Xxxxxx X. Xxxxx | ||
Xxxxxx X. Xxxxx | |||
By: | /s/ Xxxxx X. Xxxxx | ||
Xxxxx X. Xxxxx | |||
FBB Associates | |||
By: | /s/ Xxxxxx X. Xxxxx | ||
Name: Xxxxxx X. Xxxxx | |||
Title: Partner |